Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis

Emiliano Trías, Luis Barbeito|Journal of Neuroinflammation|2016

Cited by 148